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of Mesenchymal Stem Cell-derived exosomes on cognitive and cellular function in an AD mouse model.
Overall, this is potentially a promising report presenting several sets of the novel and highly relevant results demonstrating that Mesenchymal Stem Cell-derived exosomes possess neuroprotective properties.
However, in its current form, this study has several major issues that should be carefully addressed.
Critiques:
General:
1. Introduction. Recent work by Mariana A. de Godoy et al. "Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers," which is highly related to the study should be referenced in the introduction section (de Godoy et al., 2018) .
2. Methods. a) Induction of AD and treatments administration. There is a problem with the method used to generate and treat AD mice. The authors injected the animals twice into the same region of the brain. In this particular case with an acute model of AD, I would apply chronic cannulation as an alternative for repeated acute injections (Faucher et al., 2016) , or intracerebroventricular injection of Amyloid-β peptides and hippocampal injection of exosomes (or vice versa). Moreover, the coordinates have not been chosen correctly for the injections. According to the coordinates mentioned in the methods section, the injection site is outside of the dentate gyrus and even hippocampus! Additionally, the researchers administered the mice bilaterally with 3 µL of Aβ solution, which is an enormous amount for a single injection into the mice hippocampus (average volume is about 0.5-1 µL).
The injection rate of 0.5 µL/min was very high as well. The regular recommended rate is about 0.1 µL/min (Faucher et al., 2016) . 
